Renard Éric, Place Jérôme, Benbrahim Najib, Diouri Omar, Farret Anne
Faculté de médecine 641 av. du Doyen Gaston-Giraud, 34090 Montpellier, France; CHU Lapeyronie 371 av. du Doyen Gaston-Giraud, 34090 Montpellier, France; Centre d'Investigation Clinique du CHRU de Montpellier-CHU Saint-Eloi, 80, avenue Augustin Fliche, 34295 Montpellier Cedex 5, France.
Université de Montpellier 1, 63 rue Auguste Broussonnet, 34090 Montpellier, France.
Rev Infirm. 2017 Apr;66(230):35-37. doi: 10.1016/j.revinf.2017.02.010.
Almost 45 000 patients with type 1 diabetes are concerned in France by outpatient insulin pump therapy. The first systems of insulin pump therapy guided by glycaemia have evolved driven by the work carried out by multi-disciplinary research teams. Today, the outpatient treatment of type 1 diabetes by an artificial pancreas is on the point of becoming reality.
